IP Library Granted Patent US 8,835,671
Granted Patent B2
US 8,835,671 · App. 13/463,648 · Granted Sep 16, 2014

Crosslinked zwitterionic hydrogels

Inventors: Shaoyi Jiang (Redmond, WA); Hong Xue (Pleasanton, CA); Louisa R. Carr (Seattle, WA)
Assignee: University of Washington through its Center for Commercialization
C07C229/12A61L31/10A61L27/52A61K41/0019A61L29/145C08F26/02A61L29/085A61L31/145A61L27/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,835,671
App. No.
13/463,648
Granted
Sep 16, 2014
Kind
B2
Abstract

Zwitterionic crosslinking agents, crosslinked zwitterionic hydrogels prepared from copolymerization of zwitterionic monomers with the zwitterionic crosslinking agent, methods for making crosslinked zwitterionic hydrogels, and devices that include and methods that use the crosslinked zwitterionic hydrogels.

Claims (15)

1. A compound represented by the formula:

wherein

R 1 and R 2 are independently selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;

R 3 is selected from the group consisting of C1-C6 alkyl, C6-C12 aryl, CH 2 ═C(R 1 )-L 1 -, and CH 2 ═C(R 2 )-L 2 -;

L 1 and L 2 are independently selected from the group consisting of —C(═O)O—(CH 2 ) n — and —C(═O)NH—(CH 2 ) n —, wherein n is an integer from 1 to 20;

L 3 is —(CH 2 ) n —, where n is an integer from 1 to 20;

A 1 is C, S, SO, P, or PO;

X − is the counter ion associated with the N + cationic center; and

M + is a counterion associated with the (A 1 =O)O − anionic center.

2. The compound of claim 1 , wherein R 1 , R 2 , and R 3 are independently selected from the group consisting of C1-C6 alkyl.

3. The compound of claim 1 , wherein L 1 and L 2 are —C(═O)O—(CH 2 ) n —, wherein n is 1-6.

4. The compound of claim 1 , wherein L 3 is —(CH 2 ) n —, where n is an integer from 1-6.

5. The compound of claim 1 , wherein A 1 is C or SO.

6. The compound of claim 1 , wherein M + at each occurrence is a metal or organic ion.

7. The compound of claim 1 , wherein X − at each occurrence is halide, carboxylate, alkylsulfonate, sulfate; nitrate, perchlorate, tetrafluoroborate, hexafluorophosphate, trifluoromethylsulfonate, bis(trifluoromethylsulfonyl)amide, lactate, or salicylate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2012
From: JIANG, SHAOYI; XUE, HONG; YANG, WEI; CARR, LOUISA R.
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 028844/0264 →
Continuity (3)
Continuation PCTUS2010055875 · Nov 8, 2010
Provisional Application 61259074 · Nov 6, 2009
Related Publication 20120322939A1 · Dec 20, 2012